Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Budigalimab +1 More for Pancreatic Cancer
Recruiting1 awardPhase 2
San Antonio, Texas
This trial will test the effectiveness and safety of TTX-030 with or without budigalimab along with chemotherapy in patients with metastatic PDAC who have not received prior treatment for metastatic
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.